HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endovascular repair of thoracic aortic pathology.

Abstract
Endovascular repair of thoracic aortic pathology is an evolving and increasingly attractive alternative to open repair. Endograft technology and delivery systems have improved rapidly since their introduction in the 1990s, and early and mid-term results for currently available devices are promising. No individual device has proven to be superior as no comparative trials have been performed. However, each available device is unique in its characteristics to treat aortic disease: GORE(®) TAG(®) (WL Gore and Associates, AZ, USA), Zenith(®) (TX1(®) and TX2(®), Cook, IN, USA), and Talent™ (Medtronic Vascular, CA, USA). In addition to a prerequisite set of endovascular skills, a detailed knowledge of different graft designs and an understanding of aortic pathology significantly affect the efficacy of endovascular repair of thoracic aortic disease. This article focuses on the currently available devices, their characteristics and pivotal clinical trial results.
AuthorsMisaki Kiguchi, Rabih A Chaer
JournalExpert review of medical devices (Expert Rev Med Devices) Vol. 8 Issue 4 Pg. 515-25 (Jul 2011) ISSN: 1745-2422 [Electronic] England
PMID21728735 (Publication Type: Journal Article, Review)
Topics
  • Aorta, Thoracic (pathology, surgery)
  • Blood Vessel Prosthesis
  • Device Approval
  • Endovascular Procedures (methods)
  • Humans
  • Spinal Cord (blood supply, pathology)
  • Wound Healing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: